Cheng et al. reported that RSV promotes phosphorylation of nuclear factor erythroid 2-related factor-2 (Nrf2) in mouse models, which makes this hypothesis stronger that the RSV might be helpful in the diabetes therapy by the protective effects against dysfunction of beta-cells. The gene discussed is NFE2L2; the disease is diabetes mellitus.